5/14
08:00 am
akba
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference
Low
Report
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference
5/11
09:34 am
akba
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA) [Yahoo! Finance]
Medium
Report
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA) [Yahoo! Finance]
5/9
07:06 am
akba
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
5/9
07:00 am
akba
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Low
Report
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
5/2
08:30 am
akba
Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights
Medium
Report
Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights
5/1
04:05 pm
akba
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/29
11:07 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/28
10:44 am
akba
When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)? [Yahoo! Finance]
Low
Report
When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)? [Yahoo! Finance]
4/23
06:10 am
akba
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease [Yahoo! Finance]
Low
Report
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease [Yahoo! Finance]
4/19
11:01 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Neutral
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/11
02:03 am
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/4
06:08 pm
akba
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management [Seeking Alpha]
Low
Report
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management [Seeking Alpha]
4/3
02:04 am
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/2
04:05 pm
akba
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/1
09:31 am
akba
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
High
Report
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
3/28
12:01 pm
akba
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia [Yahoo! Finance]
Medium
Report
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia [Yahoo! Finance]
3/28
10:14 am
akba
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
3/28
09:31 am
akba
Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?
High
Report
Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?
3/28
09:19 am
akba
Stocks Set To Close Blowout Week, Month And Quarter At All-Time High; Gold Soars To Record [zero hedge]
High
Report
Stocks Set To Close Blowout Week, Month And Quarter At All-Time High; Gold Soars To Record [zero hedge]
3/28
08:28 am
akba
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD [Yahoo! Finance]
High
Report
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD [Yahoo! Finance]
3/28
05:42 am
akba
Biggest stock movers today: RH, AKBA, and more [Seeking Alpha]
High
Report
Biggest stock movers today: RH, AKBA, and more [Seeking Alpha]
3/27
08:46 pm
akba
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis [Yahoo! Finance]
Medium
Report
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis [Yahoo! Finance]
3/27
08:26 pm
akba
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Medium
Report
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
3/26
11:02 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
High
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/22
09:31 am
akba
Thinking about buying stock in Akebia Therapeutics, Boeing, Aquestive Therapeutics, General Electric, or Canoo?
Medium
Report
Thinking about buying stock in Akebia Therapeutics, Boeing, Aquestive Therapeutics, General Electric, or Canoo?